IL6 and COVID-19: A cross-sectional study found a correlation between higher inflammatory markers in the serum of patients with more severe COVID-19, including cytokines such as IL-2R, IL-6, and TNF-a, suggesting that the inflammation level may predict disease severity in COVID-19 [15].